Monday 16 November 2026
Salisbury Foundation Trust

FOI_9624

Internal Reference Number: FOI_9624

Date Request Received: 01/09/2026 00:00:00

Date Request Replied To: 22/10/2026 00:00:00

This response was sent via: By Email

Request Summary: Biologic therapies in COPD

Request Category: Companies

 
Question Number 1:
I am trying to understand the uptake of COPD biologics in England and wanted to ask a couple of questions about how Salisbury NHSFT are dealing with their introduction so far. For clarity, when I talk about COPD biologics I am talking about either dupilimab or mepolizumab.

Are you using any system to record when a patient initiates a biologic for their COPD? For example, this could include (but not be limited to) Blueteq or the National Respiratory Audit Programme reports.

a. If yes, please could you name what system you are using?



 
Answer To Question 1:
1. No
 
Question Number 2:
To date (i.e. up to today’s date of 1stth September 2026), how many patients have initiated a COPD biologic in your trust?

a. How many of these initiations were for patients being treated with dupilimab and how many of them were mepolizumab?
 
Answer To Question 2:
0 results
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

Salisbury NHS Foundation Trust, Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2026 Salisbury NHS Foundation Trust
Trust Values